dihexa cancer risk hgf c met

dihexa cancer risk hgf c met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International Dihexa (PNB-0408) | c-Met/HGFR Activator

Name: dihexa cancer risk hgf c met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International Dihexa (PNB-0408) | c-Met/HGFR Activator
Brand: msw-creativ-solutions.de
SKU: 7001386500
Price: 20.59 USD
Availability: InStock
Rating: 4.4779 (10 reviews)

Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link Hepatocyte growth factor (HGF) binding c Met activates signaling Download Scientific Diagram dihexa cancer risk hgf c met Targeting the HGF c MET pathway in advanced pancreatic cancer c Met Signaling as a Therapeutic Target in Head : The Cancer Journal

SKU: 7001386500 · From msw-creativ-solutions.de

4.5

USD20.59 USD66.59

Pay in 4 interest-free payments of $5.15 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 20 - Sep 25

Description

Further studies and additional models are needed to clarify whether this reflects increased toxicity or immune activation

Reverse transcription PCR (RT-PCR) was performed using a commercial kit, with -actin as the housekeeping gene for normalization

Products are manufactured in U.S.-based facilities operating under applicable cGMP standards

J Clin Invest 122:24542468 Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR (2006) IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program